Facts about EXSERVAN

The first and only oral film formulation of riluzole.1

  • Dissolves on the top of the tongue to deliver 50 mg of riluzole1
  • Demonstrated bioequivalence to riluzole tablets (RILUTEK®) with a similar rate of absorption1-3
  • Average time to dissolve: 2 minutes4
  • Safety and tolerability similar to riluzole tablets (RILUTEK)1,3
  • Rectangular-shaped, with a honey lemon flavor1
  • Each film is individually packaged in a foil pouch1

Do your ALS patients need a different approach to treatment?

EXSERVAN™ Packaging

Not actual size.

Mitsubishi Tanabe Pharma America, Inc. is committed to advancing treatment options for people living with ALS.

Discover another treatment option to consider in your patients' ALS journeys

Learn More
  1. EXSERVAN (riluzole) Prescribing Information. Jersey City, NJ: Mitsubishi Tanabe Pharma America, Inc.; 2021.
  2. Center for Drug Evaluation and Research (US). 2017. EXSERVAN (riluzole). Washington DC: US Food and Drug Administration, Center for Drug and Evaluation Research. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/212640Orig1s000MedR.pdf. Accessed April 2, 2021.
  3. RILUTEK® (riluzole) Prescribing Information. Cary, NC: Covis Pharmaceuticals Inc.; 2016.
  4. Data on File. Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ.